EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Current Pharmaceutical Biotechnology


 

Status
active
Indexing
Chemical Abstracts, MEDLINE, BIOSIS, EMBASE, BIOBASE, SCI Expanded, Index to Scientific Reviews, Biochemistry, Biophysics citation index , BIOSIS Reviews Report and Meetings, Journal Citation Reports/Science Edition, Biotechnology Citation Index®, Google, Google Scholar, Genamics JournalSeek, Scopus, EMBiology, MediaFinder®-Standard Periodical Directory
Subject

Source type
Journal
Publisher
ISBN ISSN
1389-2010
E ISSN
1873-4316
First volume
1
Last volume
11+
Publish city
Hilversum
Homepage
Description

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.



Related links:









Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )